Punekar et al., 2022 - Google Patents
A transcriptomics-based bioinformatics approach for identification and in vitro screening of FDA-approved drugs for repurposing against dengue virus-2Punekar et al., 2022
View HTML- Document ID
- 6345917953464530754
- Author
- Punekar M
- Kasabe B
- Patil P
- Kakade M
- Parashar D
- Alagarasu K
- Cherian S
- Publication year
- Publication venue
- Viruses
External Links
Snippet
The rising incidence of dengue virus (DENV) infections in the tropical and sub-tropical regions of the world emphasizes the need to identify effective therapeutic drugs against the disease. Repurposing of drugs has emerged as a novel concept to combat pathogens. In …
- 239000003814 drug 0 title abstract description 103
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Panda et al. | In vitro antiviral activity of α-mangostin against dengue virus serotype-2 (DENV-2) | |
| El-Demerdash et al. | Comprehensive virtual screening of the antiviral potentialities of marine polycyclic guanidine alkaloids against SARS-CoV-2 (COVID-19) | |
| Pasquereau et al. | Resveratrol inhibits HCoV-229E and SARS-CoV-2 coronavirus replication in vitro | |
| Cho et al. | Native high-density lipoproteins (HDL) with higher paraoxonase exerts a potent antiviral effect against SARS-CoV-2 (COVID-19), while glycated HDL lost the antiviral activity | |
| Weichseldorfer et al. | Past HIV-1 medications and the current status of combined antiretroviral therapy options for HIV-1 patients | |
| Russo et al. | COVID-19 and heart: from clinical features to pharmacological implications | |
| Punekar et al. | A transcriptomics-based bioinformatics approach for identification and in vitro screening of FDA-approved drugs for repurposing against dengue virus-2 | |
| Lai | Small molecule HIV-1 attachment inhibitors: discovery, mode of action and structural basis of inhibition | |
| Chen et al. | Micafungin inhibits dengue virus infection through the disruption of virus binding, entry, and stability | |
| Lin et al. | CXCL10 signaling contributes to the pathogenesis of arthritogenic alphaviruses | |
| Yang et al. | Gypenoside inhibits bovine viral diarrhea virus replication by interfering with viral attachment and internalization and activating apoptosis of infected cells | |
| Panya et al. | A synthetic bioactive peptide derived from the asian medicinal plant Acacia Catechu binds to dengue virus and inhibits cell entry | |
| Nagahawatta et al. | Polyphenolic compounds isolated from marine algae attenuate the replication of SARS-CoV-2 in the host cell through a multi-target approach of 3CLpro and PLpro | |
| Zheng et al. | Active components from Cassia abbreviata prevent HIV-1 entry by distinct mechanisms of action | |
| Chable-Bessia et al. | Low selectivity indices of ivermectin and macrocyclic lactones on SARS-CoV-2 replication in vitro | |
| Khalifa et al. | After the hurricane: anti-COVID-19 drugs development, molecular mechanisms of action and future perspectives | |
| Gao et al. | Fludarabine inhibits infection of Zika virus, SFTS phlebovirus, and Enterovirus A71 | |
| Kongsomros et al. | Anti-SARS-CoV-2 activity of extracellular vesicle inhibitors: screening, validation, and combination with remdesivir | |
| Keramidas et al. | Inhibition of PERK kinase, an orchestrator of the unfolded protein response (UPR), significantly reduces apoptosis and inflammation of lung epithelial cells triggered by SARS-CoV-2 ORF3a protein | |
| Tseng et al. | Antidepressant sertraline is a broad-spectrum inhibitor of enteroviruses targeting viral entry through neutralization of endolysosomal acidification | |
| Chen et al. | Grape seed proanthocyanidins inhibit replication of the dengue virus by targeting NF-kB and MAPK-mediated cyclooxygenase-2 expression | |
| Bakovic et al. | Inhibitors of venezuelan equine encephalitis virus identified based on host interaction partners of viral non-structural protein 3 | |
| Theerawatanasirikul et al. | Non-nucleoside inhibitors decrease foot-and-mouth disease virus replication by blocking the viral 3Dpol | |
| Nakanishi et al. | Ivermectin inhibits HBV entry into the nucleus by suppressing KPNA2 | |
| Wei et al. | Antiviral effects of novel 2-benzoxyl-phenylpyridine derivatives |